European Course of in vivo Preclinical Assays in Cancer Therapy

In vivo Preclinical Models in cancer

The 6th European Course of in vivo Preclinical Assays in Cancer Therapy is an extensive training program designed to educate and update the biomedical research community on current trends and technological advances in in vivo preclinical assays in cancer.
The emphasis of this course will be on the use of genetically engineered mouse models and patient-derived xenograft (PDX) models for in vivo preclinical research.
The course will cover the following topics: in vitro preclinical assays employing established tumor cell lines and functional genomics approaches, preclinical imaging, angiogenesis and metastasis, Zebrafish model, therapy resistance models and approaches, ethics and co-clinical trials.